Melacin Tablet contains a combination of Flupenthixol (0.5 mg) and Melitracen (10 mg), formulated for the management of depressive disorders and associated anxiety symptoms. Flupenthixol is a typical antipsychotic agent with anxiolytic properties, acting primarily as a dopamine receptor antagonist, which helps in stabilizing mood and reducing psychomotor agitation. Melitracen, a tricyclic antidepressant, enhances neurotransmitter activity by inhibiting the reuptake of serotonin and norepinephrine, thereby improving mood and alleviating depressive symptoms. The synergistic effect of these two active ingredients provides effective relief from mild to moderate depression, anxiety, and psychosomatic disorders. Melacin Tablet is indicated for patients exhibiting symptoms such as low mood, fatigue, irritability, and sleep disturbances. It is generally well-tolerated when administered at recommended dosages; however, caution is advised in patients with a history of cardiovascular disease, glaucoma, or epilepsy. Common side effects may include dry mouth, dizziness, and gastrointestinal discomfort. Melacin should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. It is contraindicated during pregnancy and lactation unless deemed necessary by a healthcare professional. Regular monitoring is recommended to ensure therapeutic efficacy and safety.